Evidence map›Paper›PMID 33015194›Full record

ArticleJournal of diabetes research2020

Development and Validation of a Hypoglycemia Risk Model for Intensive Insulin Therapy in Patients with Type 2 Diabetes.

Xiling Hu, Weiran Xu, Shuo Lin, Cang Zhang, Cong Ling, Miaoxia Chen

Abstract read
In one paragraph

Article in Journal of diabetes research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Artificial Intelligence to Diagnose Complications of Diabetes.Journal of diabetes science and technology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiling HuDepartment of Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Weiran XuSchool of Nursing, Sun Yat-sen University, Guangzhou 510085, China.ORCID https://orcid.org/0000-0001-8837-2914
Shuo LinDepartment of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Cang ZhangDepartment of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Cong LingDepartment of Neurosurgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.ORCID https://orcid.org/0000-0003-3953-0108
Miaoxia ChenNursing Department, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.ORCID https://orcid.org/0000-0001-6716-522X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo develop a simple hypoglycemic prediction model to evaluate the risk of hypoglycemia during hospitalization in patients with type 2 diabetes treated with intensive insulin therapy.

methodsWe performed a cross-sectional chart review study utilizing the electronic database of the Third Affiliated Hospital of Sun Yat-sen University, and included 257 patients with type 2 diabetes undergoing intensive insulin therapy in the Department of Endocrinology and Metabolism. Logistic regression analysis was used to derive the clinical prediction rule with hypoglycemia (blood glucose ≤ 3.9 mmol/L) as the main result, and internal verification was performed.

resultsIn the derivation cohort, the incidence of hypoglycemia was 51%. The final model selected included three variables: fasting insulin, fasting blood glucose, and total treatment time. The area under the curve (AUC) of this model was 0.666 (95% CI: 0.594-0.738,

conclusionsThe model's hypoglycemia prediction and the actual occurrence are in good agreement. The variable data was easy to obtain and the evaluation method was simple, which could provide a reference for the prevention and treatment of hypoglycemia and screen patients with a high risk of hypoglycemia.

Indexed as

Diabetes Mellitus, Type 2HyperglycemiaHypoglycemiaInsulinAdultBlood GlucoseFemaleHumansHypoglycemic AgentsIncidenceMaleMiddle AgedRemission InductionRisk FactorsTreatment OutcomeBlood GlucoseHypoglycemic AgentsInsulin

Identifiers

PMID33015194
PMCPMC7525304

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.